Thrombin, generated in the circulation during injury, cleaves proteinase-activated receptor 1 (PAR1) to stimulate plasma extravasation and granulocyte infiltration. However, the mechanism of thrombin-induced inflammation in intact tissues is unknown. We hypothesized that thrombin cleaves PAR1 on sensory nerves to release substance P (SP), which interacts with the neurokinin 1 receptor (NK1R) on endothelial cells to cause plasma extravasation. PAR1 was detected in small diameter neurons known to contain SP in rat dorsal root ganglia by immunohistochemistry and in situ hybridization. Thrombin and the PAR1 agonist TFLLR-NH(2) (TF-NH(2)) increased [Ca(2+)](i) >50% of cultured neurons (EC(50)s 24 mu ml(-1) and 1.9 microM, respectively), assessed using Fura-2 AM. The PAR1 agonist completely desensitized responses to thrombin, indicating that thrombin stimulates neurons through PAR1. Injection of TF-NH(2) into the rat paw stimulated a marked and sustained oedema. An NK1R antagonist and ablation of sensory nerves with capsaicin inhibited oedema by 44% at 1 h and completely by 5 h. In wild-type but not PAR1(-/-) mice, TF-NH(2) stimulated Evans blue extravasation in the bladder, oesophagus, stomach, intestine and pancreas by 2 - 8 fold. Extravasation in the bladder, oesophagus and stomach was abolished by an NK1R antagonist. Thus, thrombin cleaves PAR1 on primary spinal afferent neurons to release SP, which activates the NK1R on endothelial cells to stimulate gap formation, extravasation of plasma proteins, and oedema. In intact tissues, neurogenic mechanisms are predominantly responsible for PAR1-induced oedema.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572861PMC
http://dx.doi.org/10.1038/sj.bjp.0704152DOI Listing

Publication Analysis

Top Keywords

plasma extravasation
12
proteinase-activated receptor
8
intact tissues
8
thrombin cleaves
8
cleaves par1
8
sensory nerves
8
nk1r endothelial
8
endothelial cells
8
par1 agonist
8
nk1r antagonist
8

Similar Publications

Extracellular Vesicles From Preeclampsia Disrupt the Blood-Brain Barrier by Reducing CLDN5.

Arterioscler Thromb Vasc Biol

December 2024

Vascular Physiology Laboratory, Department of Basic Sciences, Universidad del Bío-Bío, Chillán, Chile (H.S., B.I., M.C., F.T., E.E.-G., J.A., C.E.).

Background: The physiopathology of life-threatening cerebrovascular complications in preeclampsia is unknown. We investigated whether disruption of the blood-brain barrier, generated using circulating small extracellular vesicles (sEVs) from women with preeclampsia or placentae cultured under hypoxic conditions, impairs the expression of tight junction proteins, such as CLDN5 (claudin-5), mediated by VEGF (vascular endothelial growth factor), and activation of KDR (VEGFR2 [VEGF receptor 2]).

Methods: We perform a preclinical mechanistic study using sEVs isolated from plasma of pregnant women with normal pregnancy (sEVs-NP; n=9), sEVs isolated from plasma of women with preeclampsia (sEVs-PE; n=9), or sEVs isolated from placentas cultured in normoxia (sEVs-Nor; n=10) or sEVs isolated from placentas cultured in hypoxia (sEVs-Hyp; n=10).

View Article and Find Full Text PDF

A 56-year-old female with class 3 obesity, was previously submitted to laparoscopic sleeve gastrectomy (LSG) two weeks before current admission. The patient was admitted due to fever, abdominal pain and vomiting. CT revealed a 13.

View Article and Find Full Text PDF
Article Synopsis
  • Superficial mucoceles (SM) are benign, small vesicles in the oral mucosa caused by salivary gland duct rupture, often found on the lower lip.
  • Immune checkpoint blockade treatments used in cancer can lead to skin-related side effects in 40-50% of patients, with severe cases occurring in 1-2%, such as Stevens-Johnson syndrome.
  • A case study highlighted the successful treatment of multiple SM in a patient with squamous cell carcinoma, utilizing plasma and electrocoagulation methods, and aimed to improve understanding of mucosal reactions to cancer therapies.
View Article and Find Full Text PDF

NON-INVASIVE METHOD OF MONITORING INTRACRANIAL PRESSURE FOR THE EVALUATION OF HEPATIC ENCEPHALOPATHY.

Arq Gastroenterol

November 2024

Faculdade de Medicina de São José do Rio Preto, Departamento de Cardiologia e Cirurgia Cardiovascular, São José do Rio Preto, São Paulo , Brasil.

Article Synopsis
  • The study investigates a new non-invasive method for monitoring intracranial pressure (ICP) in patients with liver diseases and hepatic encephalopathy (HE), aiming to provide an alternative to invasive techniques.
  • It uses a specific equipment, Brain4Care® BWS, to analyze ICP pulse morphology and correlates it with clinical signs of HE, focusing on key peaks that indicate intracranial compliance.
  • Results show significant differences in ICP patterns between patients with and without HE, highlighting the method's potential for effective monitoring and assessment in clinical settings.
View Article and Find Full Text PDF

Systemic capillary leak syndrome.

Nat Rev Dis Primers

November 2024

Division of Nephrology, Departments of Internal Medicine and Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

The vascular endothelial barrier maintains intravascular volume and metabolic homeostasis. Although plasma fluids and proteins extravasate continuously from tissue microvasculature (capillaries, post-capillary venules), systemic vascular leakage increases in critical illness associated with sepsis, burns and trauma, among others, or in association with certain drugs or toxin exposures. Systemically dysregulated fluid homeostasis, which can lead to hypovolaemia, hypotensive shock and widespread tissue oedema, has been termed systemic capillary leak syndrome (SCLS) when overt secondary causes (for example, heart or liver failure) are excluded.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!